Common Transition Metal Oxide Nanomaterials in Electrochemical Sensors for the Diagnosis of Monoamine Neurotransmitter‐Related Disorders

Abstract

Abstract Monoamine neurotransmitters are essential for learning, mental alertness, emotions, and blood flow, among other functions. Fatal neurological disorders that signal the imbalance of these biomolecules in the human system include Parkinson's disease, myocardial infarction, Alzheimer's disease, hypoglycemia, Schizophrenia, and a host of other ailments. The diagnosis of these monoamine neurotransmitter‐related conditions revolves around the development of analytical tools with high sensitivity for the four major monoamine neurotransmitters namely dopamine, epinephrine, norepinephrine, and serotonin. The application of electrochemical sensors made from notable metal oxide nanoparticles or composites containing the metal oxide nanoparticles for the detection of these monoamine neurotransmitters was discussed herein. More importantly, the feasibility of the application of the ZnO, CuO, and TiO 2 nanoparticle‐based electrochemical sensors for a comprehensive diagnosis of monoamine neurotransmitter‐related conditions was critically investigated in this review.